PTC Therapeutics has sold its rare pediatric disease priority review voucher (PRV) for $150 million, following FDA approval ...

Also, the trainee constables at PTC Amberpet, PTC Medchal, and RBVRR TGPA were trained in the latest procedures in the ...

PTC Therapeutics (PTCT) announced that it has entered into an agreement to sell its Rare Pediatric Disease Priority Review Voucher for $150M upon the closing of the transaction. PTC was granted the ...

Retailers like Dunelm offer plenty of cost-effective heating solutions. Despite its compact size, the £18 Plug in PTC Heater ...

With freezing temperatures settling across the UK, people are looking at cheaper ways to warm their homes for less ...

PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) reached a new 52-week high during mid-day trading on Wednesday after Robert W. Baird raised their price target on the stock from $48.00 to $52.00 ...

PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report)’s share price rose 4.8% on Tuesday after Robert W. Baird raised their price target on the stock from $48.00 to $52.00. Robert W. Baird currently ...

In a report released on November 25, Brian Abrahams from RBC Capital maintained a Hold rating on PTC Therapeutics (PTCT – Research Report), with a price target of $39.00. The company’s shares closed ...

Report with the AI impact on market trends - The global predictive maintenance (PDM) market size is estimated to grow by USD ...

Administration for these structures requires compliance, which now includes the U.S. Corporate Transparency Act (the CTA).

Kronos is cutting 83% of its workforce, while Idorsia is considering eliminating as many as 270 jobs. Elsewhere, PTC ...

The announcement means the company will be pulling the plug on the CardinALS trial after its amyotrophic lateral sclerosis ...